No abstract available
Publication types
-
Letter
-
Observational Study
MeSH terms
-
Adult
-
Aged
-
Aged, 80 and over
-
Anticoagulants / administration & dosage
-
Anticoagulants / adverse effects*
-
Betacoronavirus / pathogenicity
-
COVID-19
-
Coronavirus Infections / epidemiology
-
Coronavirus Infections / therapy*
-
Coronavirus Infections / virology
-
Female
-
Fibrinolytic Agents / administration & dosage
-
Fibrinolytic Agents / adverse effects*
-
Hemorrhage / chemically induced*
-
Hemorrhage / epidemiology
-
Host-Pathogen Interactions
-
Humans
-
Male
-
Middle Aged
-
Pandemics
-
Pneumonia, Viral / epidemiology
-
Pneumonia, Viral / therapy*
-
Pneumonia, Viral / virology
-
Prevalence
-
Risk Factors
-
SARS-CoV-2
-
Switzerland / epidemiology
-
Thrombosis / epidemiology
-
Thrombosis / prevention & control*
-
Thrombosis / virology
-
Time Factors
-
Treatment Outcome
-
Young Adult
Substances
-
Anticoagulants
-
Fibrinolytic Agents